Multiple Sclerosis Clinical Trial
Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis
Summary
The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on the quality of life of people with multiple sclerosis (MS). SVF contains components with "regenerative" properties, including stem cells that may be capable of ameliorating specific disease conditions. This study is designed to evaluate quality of life changes in individuals with MS for up to 12 months following SVF treatment.
Eligibility Criteria
Inclusion Criteria:
Subjects scheduled for a stem cell/SVF treatment
Subjects diagnosed with some form of multiple sclerosis
Subjects between the ages of 18 and 65
Subjects willing and able to sign informed consent
Subjects willing and able to perform follow up interviews and surveys
Exclusion Criteria:
Subjects for whom baseline data is not available
Subjects with additional major health diagnoses
Subjects that are pregnant or breastfeeding
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
San Diego California, 92121, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.